Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2021
DOI: 10.1016/j.amjmed.2021.06.013
|View full text |Cite
|
Sign up to set email alerts
|

Trends in Calcium Channel Blocker Use in Patients with Heart Failure with Reduced Ejection Fraction and Comorbid Atrial Fibrillation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(9 citation statements)
references
References 36 publications
2
2
0
Order By: Relevance
“…
We thank Dr Reiffel for his letter regarding our recently published article in The American Journal of Medicine. 1 We agree with many of his comments when considering how to apply the study results to clinical practice.Due to how data was collected in the registry, we do not have specifics about individual patients' heart failure etiology. We agree that atrioventricular (AV) nodal blockade is an important strategy for managing tachycardic-induced cardiomyopathy.
…”
supporting
confidence: 53%
See 1 more Smart Citation
“…
We thank Dr Reiffel for his letter regarding our recently published article in The American Journal of Medicine. 1 We agree with many of his comments when considering how to apply the study results to clinical practice.Due to how data was collected in the registry, we do not have specifics about individual patients' heart failure etiology. We agree that atrioventricular (AV) nodal blockade is an important strategy for managing tachycardic-induced cardiomyopathy.
…”
supporting
confidence: 53%
“…We thank Dr Reiffel for his letter regarding our recently published article in The American Journal of Medicine. 1 We agree with many of his comments when considering how to apply the study results to clinical practice.…”
supporting
confidence: 53%
“… 12 Even in patients with HFrEF, it was reported that 4.7–7.3% were discharged on contraindicated CCB. 13 , 14 Our study found that the proportion of patients with CCB gradually increased after LVAD and reached a plateau of ~20% after 18 months. Besides, there was also an increase in CCB treatment at different follow‐up time points from 2011 to 2017.…”
Section: Discussionmentioning
confidence: 61%
“…Besides, CCBs had exceeded angiotensin II receptor blockers (ARBs) as the most prescribed first‐line antihypertensive drugs in these patients, with 26.0–26.8% after 2013 12 . Even in patients with HFrEF, it was reported that 4.7–7.3% were discharged on contraindicated CCB 13,14 . Our study found that the proportion of patients with CCB gradually increased after LVAD and reached a plateau of ~20% after 18 months.…”
Section: Discussionmentioning
confidence: 67%
“…Percezione e gestione della salute -Comprendere la causa della loro HF, i sintomi e la scelta del trattamento. [11,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33] -Comprendere la prognosi e le diverse possibili fasi della traiettoria HF.…”
Section: Modelli Funzionali Topic Educativo Per L'assistitounclassified